{"id":3274,"date":"2021-09-07T16:16:57","date_gmt":"2021-09-07T13:16:57","guid":{"rendered":"https:\/\/staging.iasispharma.com\/en\/?p=3274"},"modified":"2026-10-30T13:29:48","modified_gmt":"2026-10-30T11:29:48","slug":"iasis-pharma-participation-in-the-4th-panhellenic-congress-of-s-s-d-a-d","status":"publish","type":"post","link":"https:\/\/iasispharma.com\/en\/all-articles\/iasis-pharma-participation-in-the-4th-panhellenic-congress-of-s-s-d-a-d\/","title":{"rendered":"IASIS PHARMA PARTICIPATION IN THE 4th PANHELLENIC CONGRESS OF S.S.D.A.D."},"content":{"rendered":"<p><strong>Grand Hyatt Hotel,<br \/>\nAthens, 2 &#8211; 5\/09\/2021<\/strong><\/p>\n<p><strong>IASIS PHARMA<\/strong> participated with physical presence in the 4<sup>th <\/sup>hybrid Panhellenic Congress under the title: <strong>\u201cDermatological diseases 2021: Past, present and future\u201d <\/strong>which was held on September 2-5 at Grand Hyatt Hotel Athens.<\/p>\n<p>At <strong>IASIS PHARMA<\/strong> exhibition stand, two of its major Dermatological products were presented:<\/p>\n<p><strong>Modiwart\u00ae<\/strong> \/ Imiquimod: modifier of the immune response system (innovative immunomodulator), indicated for the treatment of:<br \/>\na) External genital warts,<br \/>\nb) Superficial basal cell carcinoma (sBCC) and<br \/>\nc) Actinic keratosis (AK).<\/p>\n<p><strong>Isotroin\u00ae<\/strong> \/ Isotretinoin: a retinoid for the treatment of severe acne in oral form (<strong>soft caps<\/strong>) with the unique strength of <strong>40mg<\/strong> in the Greek market but also in soft caps of <strong>20mg<\/strong> &amp; <strong>10mg<\/strong>.<\/p>\n<p><img decoding=\"async\" class=\"alignnone wp-image-3272\" src=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2021\/09\/IMG_20210902_111422_1-225x300.jpg\" alt=\"img_20210902_111422_1\" width=\"300\" height=\"400\" srcset=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2021\/09\/IMG_20210902_111422_1-120x160.jpg 120w, https:\/\/iasispharma.com\/wp-content\/uploads\/2021\/09\/IMG_20210902_111422_1-200x267.jpg 200w, https:\/\/iasispharma.com\/wp-content\/uploads\/2021\/09\/IMG_20210902_111422_1-225x300.jpg 225w, https:\/\/iasispharma.com\/wp-content\/uploads\/2021\/09\/IMG_20210902_111422_1-400x533.jpg 400w, https:\/\/iasispharma.com\/wp-content\/uploads\/2021\/09\/IMG_20210902_111422_1-500x667.jpg 500w, https:\/\/iasispharma.com\/wp-content\/uploads\/2021\/09\/IMG_20210902_111422_1-600x800.jpg 600w, https:\/\/iasispharma.com\/wp-content\/uploads\/2021\/09\/IMG_20210902_111422_1-700x933.jpg 700w, https:\/\/iasispharma.com\/wp-content\/uploads\/2021\/09\/IMG_20210902_111422_1-768x1024.jpg 768w, https:\/\/iasispharma.com\/wp-content\/uploads\/2021\/09\/IMG_20210902_111422_1-800x1067.jpg 800w, https:\/\/iasispharma.com\/wp-content\/uploads\/2021\/09\/IMG_20210902_111422_1-1200x1600.jpg 1200w, https:\/\/iasispharma.com\/wp-content\/uploads\/2021\/09\/IMG_20210902_111422_1.jpg 1512w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Grand Hyatt Hotel, Athens, 2 &#8211; 5\/09\/2021 IASIS PHARMA participated with physical presence in the 4th hybrid Panhellenic Congress under the title: \u201cDermatological diseases 2021: Past, present and future\u201d which was held on September 2-5 at Grand Hyatt Hotel Athens. At IASIS PHARMA exhibition stand, two of its major Dermatological products were presented: Modiwart\u00ae \/  [&#8230;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":true,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[33,157],"tags":[],"class_list":["post-3274","post","type-post","status-publish","format-standard","hentry","category-all-articles","category-press-room-en"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7HJeP-QO","jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/3274","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/comments?post=3274"}],"version-history":[{"count":3,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/3274\/revisions"}],"predecessor-version":[{"id":3277,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/3274\/revisions\/3277"}],"wp:attachment":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/media?parent=3274"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/categories?post=3274"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/tags?post=3274"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}